Healthcare & Biotech

Novartis faces fresh patent cliff as pipeline drugs stumble in trials

Pharmaceutical company faces sequential patent expirations, with revenue loss from one drug offset by upcoming exclusivity cliff for another.

CNBC

Analyst lifts Eli Lilly price target on obesity drug momentum

CNBC raises Eli Lilly price target on sustained obesity-drug demand.

CNBC

Merck raises profit forecast after Keytruda sales beat expectations

Merck beats quarterly estimates and raises full-year profit guidance, driven by strong sales of a new Keytruda formulation.

CNBC

Eli Lilly raises full-year guidance as Zepbound, Mounjaro sales accelerate

Eli Lilly beats earnings estimates and raises full-year sales guidance, citing strong demand for obesity drugs Zepbound and Mounjaro.

CNBC

Traders wager against Chipotle ahead of earnings report

Traders are placing large bearish bets on a restaurant company ahead of earnings.

CNBC

Employers drop GLP-1 weight-loss coverage as premiums climb

Employer health plans are dropping GLP-1 drug coverage ahead of 2027, narrowing weight-loss options for workers.

CNBC

Cramer: Tech insiders recommend biotech stock over AI plays

Cramer reports tech insiders recommend a drug stock as a buy, citing unnamed sources.

CNBC

Moderna cancer vaccine enthusiasm wanes as Phase 3 data disappoints

Investor enthusiasm for Moderna's cancer vaccine candidate is waning.

MarketWatch

Biotech rally draws investors seeking exposure to drug innovation wave

Biotech stocks are rising on optimism about new drug innovation.

CNBC

Amgen drug reduces mortality 58% when paired with AstraZeneca immunotherapy

Amgen reports its drug combination reduces mortality risk by 58% in aggressive lung cancer patients.

CNBC

Weight-loss drugs threaten beer sales, major brewer tells UK bars

Heineken warns UK pubs that weight-loss drug adoption will reduce beer consumption and pub visits.

The Guardian

L'Oreal CEO cites weight loss drugs as drag on beauty sales

L'Oreal reports weight loss drugs are damaging beauty and skincare sales.

BBC News

Guatemalan smuggler gets 30 years for deaths of 53 migrants in trailer

US court sentences Guatemalan man to 30 years for operating deadly smuggling network.

Al Jazeera

Novo's experimental obesity injection produces quarter bodyweight reduction in women

Novo disclosed that CagriSema, an experimental injection, achieved greater weight reduction than its existing Wegovy treatment in late-stage testing.

CNBC

Ellie Goulding apologizes for promoting Argyle mine diamonds

The Guardian

Gabon seeks to shield iboga plant from commercial exploitation by US firms

Gabon moves to protect iboga plant from US pharmaceutical companies seeking to commercialize it.

The Guardian

Drone and balloon smuggling operations escalate along Jordan-Israel frontier

Drug trafficking intensifies along Jordan-Israel border, creating new organized crime corridor in Middle East.

Al Jazeera

Sickle cell treatments show promise despite barriers to patient access

Sickle cell gene therapies show clinical promise but face barriers to patient access and adoption.

CNBC

Major health systems launch longevity medicine programs as field gains traction

New York Times examines whether longevity medicine is entering mainstream adoption and investment.

The New York Times

South Australia's inaugural Michelin-starred restaurants number eleven establishments

Michelin Guide awards inaugural stars to 11 Australian restaurants, signaling prestige dining market expansion in the region.

BBC News

Walmart expands worker benefits to include free diabetes and respiratory medications

Walmart expands employee benefits to cover GLP-1 drugs, inhalers, and insulin at no cost.

CNBC

CEO argues reviving prehistoric animals could advance human health and conservation

Colossal Biosciences leader contends that resurrecting vanished species may yield benefits for medicine, environmental protection, and biological research.

CNBC

Pokémon card prices climb as collectors navigate market complexities

CNBC

Butter experiences cultural resurgence as specialty shops and collectors embrace the dairy product

Global butter demand has surged, reversing a long decline in consumption of the dairy product.

The Guardian

Chief mate sentenced to 30 years after cocaine discovered aboard cargo vessel

Seafarer imprisoned for cocaine smuggling despite lack of evidence; raises questions about maritime law enforcement and due process.

The Guardian

Appetite-suppressing medications weigh on restaurant sales and traffic

Weight loss drugs reduce diner appetite, pressuring restaurant traffic and spending.

The New York Times

Eli Lilly and Novo Nordisk pursue amylin-based treatments for obesity

Eli Lilly and Novo Nordisk are developing amylin-based obesity drugs to follow their GLP-1 successes.

CNBC

Twice-yearly HIV injection shows promise amid access concerns

HIV prevention drug advances as breakthrough, raising questions about equitable global access and distribution.

Al Jazeera

Eli Lilly's dual-drug obesity treatment demonstrates stronger weight reduction in Phase 2

Eli Lilly's combination obesity treatment shows improved weight loss results in mid-stage trial.

CNBC

Experimental HIV preventive injection raises concerns over global availability

New HIV vaccine candidate shows promise; access and distribution questions emerge.

Al Jazeera

Grindr buys telehealth startup for $250 million to enter healthcare

Grindr acquires telehealth provider PurposeMed for $250 million, diversifying beyond dating into healthcare services.

CNBC

Novo Nordisk's oral obesity drug proves effective for patients transitioning from injections

Novo Nordisk's Wegovy oral formulation maintains weight-loss efficacy in real-world patients switching from injectable GLP-1 drugs.

CNBC

Two Indian nationals face charges for importing fake Ozempic from China

Federal prosecutors indicted two individuals for smuggling counterfeit versions of the diabetes drug into the United States.

CNBC

Affluent individuals invest heavily in longevity treatments despite medical skepticism

Wealthy Americans spend up to $250,000 annually on longevity care; doctors weigh in on efficacy.

CNBC

Novo Nordisk inks second licensing agreement after investor pushback

Novo Nordisk signs second licensing deal following recent investor relations setback.

MarketWatch

Wearable ring maker Oura moves toward public market debut

Oura, a wearable health-tracking ring maker, is preparing for an initial public offering.

MarketWatch

Ozempic patients advised to undergo regular eye screenings for potential sight complications

Ozempic users should get routine eye exams to assess vision loss risk, per MarketWatch health guidance.

MarketWatch

Oura delays public offering plans amid market volatility

Oura, a smart-ring maker, postpones its IPO citing market uncertainty.

NPR · CNBC

Oura Health debuts on public markets through major initial offering

Oura Health goes public in a major IPO, bringing wearable health-tracking technology to public markets.

NPR

Biotech investment in anti-aging races past scientific validation

Longevity science claims are outpacing evidence, raising questions about biotech and healthcare investment validity.

Al Jazeera